# Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

Study · id `cardio:ct-nct01002547` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01002547](<https://clinicaltrials.gov/study/NCT01002547>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01002547

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT01002547. Randomized; triple masking; primary purpose treatment. Start 2010-06-24 (actual); primary completion 2016-09-30 (actual). Results posted on 2018-09-11.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT01002547, source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)
- Started: 2010-06-24 (actual) (ClinicalTrials.gov record NCT01002547, source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)
- Primary completion: 2016-09-30 (actual) (ClinicalTrials.gov record NCT01002547, source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)
- Completion: 2016-12-31 (actual) (ClinicalTrials.gov record NCT01002547, source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)
- Results first posted: 2018-09-11 (ClinicalTrials.gov record NCT01002547, source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01002547, source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01002547-2018-09-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
- Acronym: VA NASH
- Condition: Nonalcoholic Steatohepatitis
- Intervention (Drug): pioglitazone-placebo
- Intervention (Drug): pioglitazone
- Intervention (Dietary supplement): Vitamin E
- Intervention (Drug): pioglitazone-placebo
- Intervention (Dietary supplement): Vitamin E
- Intervention (Drug): Vitamin E-placebo
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial (`cardio:pubmed-31332029`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 04040ec2839846033751490be5adc336cf0c937ed7b05e4f5a9741173fcb18fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
